등록된 논문 166건

※ 클릭시 해당 논문페이지로 이동합니다.

• KCSG HB20-08간담췌암분과

  Regorafenib plus nivolumab in unresectable hepatocellular carcinoma: the phase 2 RENOBATE trial

  • 저널 Nat Med. 2024 Mar;30(3):699-707.
  • 제1저자 김형돈, 정세영
  • 교신저자 유창훈, 고준영

• HN16-08/ HN14-01두경부식도암

  Analysis of Response and Progression Patterns of Tyrosine Kinase Inhibitors in Recurrent or Metastatic Adenoid Cystic Carcinoma: A Post Hoc Analysis of Two KCSG Phase II Trials

  • 저널 Cancer Res Treat . 2024 Apr 15.
  • 제1저자 김유진
  • 교신저자 김범석

• NANA

  Precision Oncology Clinical Trials: A Systematic Review of Phase II Clinical Trials with Biomarker-Driven, Adaptive Design

  • 저널 Cancer Res Treat . 2024 May 7.
  • 제1저자 하혜림, 이희연
  • 교신저자 강진형, 박혜성

• KCSG ST22-06위암분과

  Real-world outcomes of third-line immune checkpoint inhibitors versus irinotecan-based chemotherapy in patients with advanced gastric cancer: a Korean, multicenter study (KCSG ST22-06)

  • 저널 BMC Cancer. 2024 Feb 23;24(1):252.
  • 제1저자 임성희
  • 교신저자 이근욱, 라선영

• KCSG PC21-07완화의료

  Clinical implication of megestrol acetate in metastatic gastric cancer: a big data analysis from Health Insurance Review and Assessment (HIRA) database

  • 저널 Support Care Cancer . 2024 Mar 26;32(4):249.
  • 제1저자 이창민, 강정훈
  • 교신저자 고세일

• KCSG BR15-17유방암

  Pemetrexed plus vinorelbine versus vinorelbine monotherapy in patients with metastatic breast cancer (KCSG-BR15-17): A randomized, open-label, multicenter, phase II trial

  • 저널 Eur J Cancer. 2024 Jan:197:113456.
  • 제1저자 이대원, 정경해
  • 교신저자 이경훈, 임석아

• KCSG HN18-08두경부식도암

  A phase 2 multicenter study of docetaxel-PM and trastuzumab-pkrb combination therapy in recurrent or metastatic salivary gland carcinomas

  • 저널 Cancer . 2023 Oct 1;129(19):2966-2974.
  • 제1저자 이지윤
  • 교신저자 안명주

• KCSG LU19-04폐암

  Phase III, Randomized Study of Atezolizumab Plus Bevacizumab and Chemotherapy in Patients With EGFR- or ALK-Mutated Non-Small-Cell Lung Cancer (ATTLAS, KCSG-LU19-04)

  • 저널 J Clin Oncol. 2024 Aug 1;42(22):2725.
  • 제1저자 박세훈
  • 교신저자 안명주

• KCSG HN15-16두경부식도암

  Personalized Biomarker-Based Umbrella Trial for Patients With Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma: KCSG HN 15-16 TRIUMPH Trial

  • 저널 J Clin Oncol. 2024 Feb 10;42(5):507-517.
  • 제1저자 김범석
  • 교신저자 윤환중, 김혜련, 김상우

• KCSG UN14-13희귀암

  A phase II study on the efficacy of regorafenib in treating patients with c-KIT-mutated metastatic malignant melanoma that progressed after previous treatment (KCSG-UN-14-13)

  • 저널 Eur J Cancer . 2023 Nov:193:113312. doi: 10.1016/j.ejca.2023.113312.
  • 제1저자 김규현, 정민규
  • 교신저자 신상준

12345